National Institutes of Health
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing June 2, 2027.
Jun 2, 2027
(306d left)